Published in Scand J Immunol on July 01, 1982
Differential expression of Ia antigens by rheumatoid synovial lining cells. J Clin Invest (1987) 1.18
Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diagn Lab Immunol (2003) 0.95
Evidence for B cell activation in patients with active rheumatoid arthritis. Clin Exp Immunol (1984) 0.91
Spontaneous and induced immunoglobulin secretion by synovial fluid B lymphocytes in rheumatoid arthritis. Ann Rheum Dis (1984) 0.81
Synthesis of antibodies, including antiviral antibodies, in the knee joints of patients with arthritis. Ann Rheum Dis (1985) 0.80
The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes. Clin Exp Immunol (1988) 0.78
Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis (1986) 0.78
High IgE in rheumatoid arthritis (RA) patients is complexed with anti-IgE autoantibodies. Clin Exp Immunol (1999) 0.76
Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis. Ann Rheum Dis (1985) 0.75
STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output. J Clin Invest (1928) 45.56
STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes. Arthritis Rheum (1991) 2.20
Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest (2001) 1.70
Bone metabolism in endurance trained athletes: a comparison to population-based controls based on DXA, SXA, quantitative ultrasound, and biochemical markers. Calcif Tissue Int (1997) 1.61
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58
HL-A antigens in sarcoidosis. Tissue Antigens (1973) 1.55
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Antigen binding cells in tolerant animals. Nature (1970) 1.35
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
B-cell mitogenic effects on human lymphocytes of rabbit anti-human beta 2-microglobulin. Scand J Immunol (1975) 1.27
The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23
Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion (1998) 1.21
HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Hum Immunol (1987) 1.20
Coxarthrosis and farm work: a case-referent study. Am J Ind Med (1997) 1.17
Complete heart block--another HLA B27 associated disease manifestation. Tissue Antigens (1983) 1.16
CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol (1993) 1.14
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14
Cytotoxicity by nonimmune allogeneic lymphoid cells. Specific suppression by antibody treatment of the lymphoid cells. J Exp Med (1967) 1.12
Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11
Induction of antibody synthesis in human B lymphocytes by different polyclonal B cell activators: evaluation by direct and indirect PFC assays. Immunol Rev (1979) 1.10
Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol (1998) 1.08
The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction. Immunogenetics (1982) 1.07
B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev (1984) 1.07
HLA phenotypes and diabetic retinopathy. Diabetologia (1978) 1.06
HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol (1976) 1.04
Effects of some immunosuppressive procedures on myasthenia gravis. Ann N Y Acad Sci (1976) 1.04
Optimal conditions for polyclonal antibody secretion and DNA synthesis in human blood and spleen lymphocytes by lipopolysaccharide. Scand J Immunol (1978) 1.04
Antibody production and DNA synthesis of human lymphocyte subpopulations induced by PPD tuberculin. Clin Exp Immunol (1979) 1.03
The use of bacteria for the functional characterization of human lymphocyte subpopulations in various lymphoid organs. Scand J Immunol (1978) 1.03
HLA-A,B,C and DR antigens in psoriasis. Tissue Antigens (1981) 1.00
Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus. J Diabet Complications (1991) 1.00
Neutropenia and insufficiency of the exocrine pancreas. Acta Paediatr Scand (1967) 1.00
Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99
HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol (1985) 0.99
Unilateral, isometric bite force in 8-68-year-old women and men related to occlusal factors. Scand J Dent Res (1990) 0.99
Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. Hum Immunol (1984) 0.97
Antigenic markers on mouse lymphoid cells: the presence of MBLA on antibody forming cells and antigen binding cells. Cell Immunol (1972) 0.96
The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96
Cytotoxic effects in vitro by lymphoid cells from specifically tolerant animals. Immunology (1969) 0.96
HLA--determination in families with hereditary ataxia. Tissue Antigens (1978) 0.95
Tuberculous meningitis: immune reactions within the central nervous system. Scand J Immunol (1981) 0.95
Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids. Eur J Immunol (1996) 0.94
HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens (1978) 0.94
Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF. Acta Neurol Scand (1979) 0.92
Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation (1996) 0.91
Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis (1996) 0.91
Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations. Clin Exp Immunol (1977) 0.91
Studies on the major histocompatibility system in patients with ankylosing spondylitis. Tissue Antigens (1975) 0.90
Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood (1983) 0.90
Identification of five lymphocyte activating determinants in man. Tissue Antigens (1975) 0.90
Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis. Clin Exp Immunol (1975) 0.90
HLA antigens in selective IgA deficiency: distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens (1984) 0.89
Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo. Scand J Immunol (1984) 0.89
Considerations of some current concepts in cancer research. J Natl Cancer Inst (1975) 0.89
Antigen-binding cells in immune and tolerant animals. Transplant Rev (1972) 0.87
A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum (1988) 0.87
The continuing carrier problem. Transplant Rev (1974) 0.87
Cytokines in rheumatoid arthritis. Ann Med (1991) 0.87
Interleukin 4 and interferon gamma production in restimulated CD4+ and CD8+ cells indicates memory type responsiveness. Scand J Immunol (1991) 0.87
[Immunoglobulin E in allergic bronchial asthma with special reference to the most important inhalation antigens]. Dtsch Med Wochenschr (1972) 0.87
Psoriasis, sacro-iliitis and peripheral arthritis occurring in patients with the same HLA haplotype. A preliminary family report and a hypothetical explanation of the interaction between MHS products. Tissue Antigens (1976) 0.87
Antigenic markers on mouse lymphoid cells: origin of cells mediating immunologic memory. Cell Immunol (1973) 0.87
HLA antigens in a psoriatic family: comparative studies with MLC, HTC, PLT and serological HLA-DR determinations. Tissue Antigens (1979) 0.86
Specificity of hapten-reactive T and B mouse lymphocytes. Affinity and avidity of T- and B-cell receptors and anti-hapten antibodies as factors of dose and time after immunization. Scand J Immunol (1974) 0.86
Follow-up of children of insulin dependent (type I) and gestational diabetic mothers. Growth pattern, glucose tolerance, insulin response, and HLA types. Acta Paediatr Scand (1984) 0.86
Inhibition of the Fc receptor of human lymphoid cells by antisera-recognizing determinants of the hla system. J Exp Med (1976) 0.86
Mitogenic properties of rabbit anti-human beta 2-microglobulin for murine B cells. Scand J Immunol (1974) 0.86
Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol (2002) 0.85
Presence of alloantigen-reactive cells in neonatally tolerized mice. Scand J Immunol (1978) 0.85
Human NK cell and ADCC reactivity against xenogeneic porcine target cells including fetal porcine islet cells. Xenotransplantation (1998) 0.84
Atopy and HLA antigens in patients with keratoconus. Acta Ophthalmol (Copenh) (1982) 0.84
In vitro characterization of immunological responsiveness of uremic patients. Nephron (1980) 0.84
Relationships between bone mass measurements and lifetime physical activity in a Swedish population. Calcif Tissue Int (1998) 0.84
Optic neuritis and distribution of genetic markers of the HLA systems. Acta Neurol Scand (1978) 0.83
Role of MLC compatibility in intrafamilial kidney transplantation. Transplantation (1976) 0.83
Continued production of xenoimmune antibodies 6-8 years after clinical transplantation of fetal pig islet-like cell-clusters. Xenotransplantation (2001) 0.83
[Treatment of chronic liver diseases with thioctic acid]. Med Klin (1967) 0.83
Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical. Transplantation (1990) 0.83
HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am J Med (1988) 0.83